| Aug 8 |
Intra-Cellular (ITCI) Q2 Loss Narrower Than Expected, Sales Beat
|
| Aug 8 |
Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference
|
| Aug 7 |
Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'
|
| Aug 7 |
Intra-Cellular Therapies, Inc. (ITCI) Q2 2024 Earnings Call Transcript
|
| Aug 7 |
Intra-Cellular Therapies (ITCI) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 7 |
Intra-Cellular Therapies names Sanjeev Narula as CFO
|
| Aug 7 |
Intra-Cellular: Q2 Earnings Snapshot
|
| Aug 7 |
Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer
|
| Aug 7 |
Intra-Cellular Therapies GAAP EPS of -$0.16 beats by $0.05, revenue of $161.3M beats by $3.42M
|
| Aug 7 |
Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance
|
